2017-12-01T14:36:08-06:00 2017-03-31 ERNST & YOUNG US LLP 425 HOUSTON STREET SUITE 600 FORT WORTH TX 76102 990 2016-04-01 751835298 SUSAN G KOMEN BREAST CANCER FDN INC % Robert Green SUSA 9728551600 5005 LBJ Freeway Suite 526 Dallas TX 752446125 ROBERT GREEN CFO 9728551600 2017-12-01 97.77.198.2 75306120173355000007 2017-12-01 P C0D8C5AAA40E33188D67D924048345967BDA0662 C9DBECFA4D5F977949E071EAE3D03995FD0A4C0E 2016 2017-02-10 21:41:12Z SUSAN G KOMEN PAULA SUE SCHNEIDER 5005 LBJ Freeway Suite 526 Dallas TX 752446125 135670783 false 7164 X www.komen.org X 1982 TX OUR MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER. 14 14 278 2965 5655 -3154 105234559 55634984 18294814 15856597 6101498 3758190 -3518888 -4906867 126111983 70342904 36875933 35357025 0 0 23559800 24717739 2754890 2584720 13589581 41567268 36543700 104757891 99203184 21354092 -28860280 248003651 220522141 106786837 92137738 141216814 128384403 X SUSAN G. KOMEN's MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER. false false 32 39856532 30755691 15812051 GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS, INCLUDING THOSE STUDYING THE BIOLOGY OF BREAST CANCER; EARLY DETECTION, DIAGNOSIS, AND PREVENTION STRATEGIES; DEVELOPMENT OF NEW APPROACHES FOR TREATMENT; AND UNDERSTANDING AND ADDRESSING DISPARITIES IN BREAST CANCER OUTCOMES, AS WELL AS RESEARCH RESOURCES AND CONFERENCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS. 32 27529563 944269 0 PROVISION OF BREAST HEALTH EDUCATION MATERIALS AND PROGRAMS, WERE BOTH MADE POSSIBLE THROUGH GRANTS TO OTHER NON-PROFIT ORGANIZATIONS AND DIRECTLY BY KOMEN TO INCREASE THE PUBLIC'S KNOWLEDGE OF BREAST CANCER, ITS RISK FACTORS, THE IMPORTANCE OF EARLY DETECTION AND BREAST SELF-AWARENESS, AND TREATMENT ACCESSIBILITY. SEE SCHEDULE O FOR ADDITIONAL DETAILS. 32 6597488 3657065 0 GRANTS TO OTHER NON-PROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION -- ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS. 73983583 true true false true false false false false false true true true false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false true 113 0 true 278 true true true false false false false true true false false false false X 14 14 false false true false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Robert Green 9728551600 5005 LBJ FREEWAY SUITE 526 Dallas TX 752446125 CONNIE O'NEILL Chair (Beg. 06/16) 1.0 0.0 X X 0 0 0 JANE ABRAHAM BOARD MEMBER 1.0 0.0 X 0 0 0 LINDA WILKINS BOARD MEMBER 1.0 0.0 X 0 0 0 NANCY G BRINKER FOUNDER/BOD MBR (LOA BEG 6/16) 1.0 0.0 X 0 0 0 LINDA CUSTARD BOD MBR (FMR CHAIR, END 06/16) 1.0 0.0 X 0 0 0 ALAN D FELD BOARD MEMBER 1.0 0.0 X 0 0 0 JANET DUNN FRANTZ BOARD MEMBER 1.0 0.0 X 0 0 0 KAYE CEILLE BOARD MEMBER 1.0 0.0 X 0 0 0 MELISSA MAXFIELD BOARD MEMBER 1.0 0.0 X 0 0 0 DR OLUFUNMILAYO OLOPADE BOARD MEMBER 1.0 0.0 X 0 0 0 DAN GLENNON BRD MEMBER/TRSR (BEG 06/16) 1.0 0.0 X X 0 0 0 MEGHAN SHANNON BOARD MEMBER 1.0 0.0 X 0 0 0 TRISH WHEATON BOARD MEMBER (BEG 06/16) 1.0 0.0 X 0 0 0 ANGELA ZEPEDA BOARD MEMBER (BEG 06/16) 1.0 0.0 X 0 0 0 Robert Green Chief Financial Officer 55.0 0.0 X 329853 0 5955 Dr Judith Salerno President & CEO (End 11/16) 55.0 0.0 X 545188 0 19860 Ellen Willmott beg 1116 secretary and Interim Pres/CEO 55.0 0.0 X 289177 0 27787 Lesley Lurie Deputy Counsel & Asst. SEC 55.0 0.0 X 221977 0 37041 Christina Alford SVP, Development 55.0 0.0 X 281944 0 5897 Victoria Wolodzko VP Research & Community Health 55.0 0.0 X 184197 0 19665 Lori Maris SVP, Affl Network (Beg 1/17) 55.0 0.0 X 149574 0 15839 Miguel Perez SVP, AFFLT NTWK (END 01/17) 55.0 0.0 X 207846 0 25228 Charlotte Walsh SVP Marketing (End 8/16) 55.0 0.0 X 175057 0 17778 Eric Montgomery VP, Information Technology 55.0 0.0 X 189336 0 43489 Catherine Olivieri VP, Human Resources 55.0 0.0 X 210924 0 41511 RIA WILLIAMS Controller 55.0 0.0 X 167257 0 39522 Gary Cole Sr Dir, (End 12/16) 55.0 0.0 X 172933 0 28225 Andrea Rader Sr Dir, Communications 55.0 0.0 X 169910 0 26315 Subhendu Rath Sr Dir, IT Enterprise Systems 55.0 0.0 X 159827 0 32855 Vanessa Hewitt Sr Dir, Internal Audit 55.0 0.0 X 155790 0 23966 3610790 0 410933 46 false true false Event 360 205 N Michigan Ave Chicago IL 60601 Event Management 5007032 Merkle Response Services PO Box 64897 Baltimore MD 21264 Donation processing 1550586 Possible Worldwide LLC 414 Olive Way Suite 500 Seattle WA 98101 Marketing services 903512 Ernst Young 3712 Solutions Center Chicago IL 60677 ACCOUNTING & TAX SVC 465032 Laurel Strategies Inc 4A Oxford Street Chevy Chase MD 20815 Consulting 440404 22 369666 19257196 36008122 82468 55634984 Affiliate Research Funds 900099 15856597 15856597 0 0 15856597 2226389 2226389 0 39575 39575 0 0 0 60737868 55600 59261667 0 1476201 55600 1531801 1531801 990579 19257196 5944296 -4953717 -4953717 0 0 0 -80858 121916 -202774 -202774 Shared Services Intercomp 900099 158228 158228 0 0 Other Income 900099 51821 0 5655 46166 210049 70342904 15812051 5655 -1109786 X 31847867 31847867 0 0 3509158 3509158 0 0 2785073 2228058 222806 334209 0 0 0 0 18062062 11224760 5025594 1811708 718980 446814 200049 72117 1913655 1189251 532456 191948 1237969 769342 344453 124174 0 0 0 0 366144 149226 158756 58162 500582 318159 127146 55277 213004 213004 0 0 2584720 2584720 90121 0 90121 0 0 0 0 0 1188152 682290 324619 181243 10811826 5965648 136025 4710153 2108676 1623681 253041 231954 0 0 0 0 1058743 673940 274943 109860 2001310 1112670 768837 119803 0 0 0 0 905082 466714 369915 68453 0 0 0 0 0 0 0 0 788014 379865 363124 45025 320843 196336 80937 43570 CONSULTING & PROF. SVCS 9739586 7456543 787063 1495980 Equip rental & maint 1539521 505793 424092 609636 Event production 3146794 1870882 934145 341767 Bank fees 1115755 713227 136787 265741 649547 440355 75111 134081 99203184 73983583 11630020 13589581 X 29456858 16364801 1657461 11434596 0 0 51130831 31823756 22743789 20419320 6498270 3718830 0 0 0 0 0 0 187029 102613 1324958 1176543 9594450 7954760 1938376 1639690 104689264 97151712 59470361 64468904 0 0 0 0 20773 20773 248003651 220522141 9477825 8991250 96670922 82800353 638090 346135 0 0 0 0 0 0 0 0 0 0 0 0 106786837 92137738 X 86358774 83312668 54533040 44746735 325000 325000 141216814 128384403 248003651 220522141 X -28860280 11713422 -2318522 0 6632969 X false true X true false X 118656952 91606572 77337857 105234559 55634984 448470924 0 0 0 0 118656952 91606572 77337857 105234559 55634984 448470924 46129219 402341705 4810808 4064746 3542123 2523145 2265964 17206786 0 0 0 0 0 351342 436740 153632 336857 51821 1330392 467008102 117418939 0.86153 0.89390 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 4996 19341 208008 254874 213004 274215 87360161 179883636 87573165 180157851 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 98255 91934 218796 274215 683200 250000 250000 250000 250000 1000000 1500000 68694 52478 66033 19341 206546 LOBBYING EXPENSES SCHEDULE C, PART II-A PUBLIC POLICY INITIATIVES HAVE THE POTENTIAL TO IMPACT PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO END BREAST CANCER FOREVER. 1376069 1786 0 1377855 1346721 29808 460 1376069 1346267 4717 4263 1346721 1325000 0 23736 2469 1346267 1325000 0 21 0 21 1325000 0.73000 0.27000 0.00000 false false 0 610067 158165 451902 2467162 2280231 186931 6517221 5516364 1000857 1639690 Long/short equity fund 16948904 F Private Equity Fund 47520000 F 64468904 0 0 X Intended use of endowment funds SCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES. FIN 48 (ASC 740) FINANCIAL STATEMENT DISCLOSURE SCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2017 OR MARCH 31, 2016. true Central America and the Caribbean 7 Grantmaking Education 380422 Central America and the Caribbean 3 Grantmaking Screening 82965 Central America and the Caribbean 2 Program services Program support 80393 East Asia and the Pacific 1 Program services Program support 45528 East Asia and the Pacific 1 Grantmaking Research 203781 Europe (Including Iceland and Greenland) 1 Grantmaking Education 40173 Europe (Including Iceland and Greenland) 4 Program services Program support 5550 Europe (Including Iceland and Greenland) 13 Grantmaking Research 1505743 Middle East and North Africa 4 Grantmaking Education 79000 Middle East and North Africa 2 Program services Program support 2587 Middle East and North Africa 1 Grantmaking Research 40000 North America 8 Program services Program support 1009414 North America 5 Grantmaking Research 681225 Russia and the Newly Independent States 1 Program services Program Support 4935 South America 1 Grantmaking Education 128550 South America 2 Program services Program support 111081 South America 1 Grantmaking Screening 130000 South America 1 Grantmaking Treatment 58131 Sub-Saharan Africa 1 Grantmaking Education 179168 Sub-Saharan Africa 4 Program services Program support 86615 57 6 63 4531347 323914 4855261 Education 89281 Middle East and North Africa EDUCATION 15000 WIRE TRANSFR Central America and the Caribbean SCREENING 60000 WIRE TRANSFR Central America and the Caribbean EDUCATION 50966 WIRE TRANSFR Central America and the Caribbean EDUCATION 35520 WIRE TRANSFR Middle East and North Africa EDUCATION 40000 WIRE TRANSFR North America RESEARCH 48000 WIRE TRANSFR South America EDUCATION 128550 WIRE TRANSFR Middle East and North Africa RESEARCH 40000 WIRE TRANSFR Sub-Saharan Africa EDUCATION 179168 WIRE TRANSFR Central America and the Caribbean EDUCATION 50000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 21000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 19611 WIRE TRANSFR South America EDUCATION, SCREENING 130000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 120000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 330000 WIRE TRANSFR Central America and the Caribbean EDUCATION 50000 WIRE TRANSFR Central America and the Caribbean EDUCATION, SCREENING 22965 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 148174 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 35693 WIRE TRANSFR South America EDUCATION, TREATMENT 58131 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION, RESEARCH 239670 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 40000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 11702 WIRE TRANSFR North America RESEARCH 80000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 135000 WIRE TRANSFR Central America and the Caribbean EDUCATION 70100 WIRE TRANSFR Central America and the Caribbean EDUCATION 50000 WIRE TRANSFR Middle East and North Africa EDUCATION 15000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 302665 WIRE TRANSFR North America RESEARCH 44900 WIRE TRANSFR North America RESEARCH 149969 WIRE TRANSFR Middle East and North Africa EDUCATION 9000 WIRE TRANSFR East Asia and the Pacific RESEARCH 203781 WIRE TRANSFR Central America and the Caribbean EDUCATION 73835 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 40173 WIRE TRANSFR North America RESEARCH 358356 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 100000 WIRE TRANSFR false false true false false false PROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES SCHEDULE F, PART I, LINE 2 AS OUTLINED IN EACH GRANT AGREEMENT, ALL GRANTEES ARE REQUIRED TO SUBMIT, AT A MINIMUM, ONE FINANCIAL AND PROGRESS REPORT WITHIN EACH YEAR OF THE GRANT TERM, AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV FOR MORE DETAILS. X X X X X true Merkle Inc Direct Marketing false 16848200 1550586 15297614 Event 360 Fundraising Consulting false 17058460 358130 16700330 Possible Worldwide LLC Marketing Consulting false 495000 Infinite Agency Marketing consulting false 154648 Bob Carter Companies Fundraising Consulting false 26356 33906660 2584720 31997944 AL AK AZ AR CA CO CT DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY 3Day 17795496 17271325 524171 0 1162 909915 836674 0 3777320 DC Race 1203891 787198 416693 0 19984 61640 12797 0 70714 2 1248388 1198673 49715 0 39425 46563 124177 21897 22028 20247775 19257196 990579 0 60571 1018118 973648 21897 3870062 5944296 -4953717 NET INCOME SUMMARY SCHEDULE G PART II GROSS RECEIPTS ARE REDUCED BY THE AMOUNT OF CONTRIBUTIONS, PER IRS INSTRUCTIONS. THE CONTRIBUTIONS FOR FISCAL YEAR 2017 WERE $19,257,196. true African Women's Cancer Awareness Assoc 8955 Edmonston Road Greenbelt MD 20770 731704355 501(C)(3) 89281 Education Alaska Native Tribal Health Consortium 4000 Ambassador Drive Anchorage AK 99508 920162721 501(C)(3) 62500 Screening American Association for Cancer Research 615 Chestnut Street 17th Fl Philadelphia PA 191064404 236251649 501(C)(3) 475000 Research American Association on Health & Disabil 110 N Washington StreetSuite 328J Rockville MD 20850 521884887 501(C)(3) 49072 Treatment American Jewish Joint Attn Itai Shamir New York NY 100174014 131656634 501(C)(3) 265000 Education American Society of Clinical Oncology Conquer Cancer Foundation Alexandria VA 22314 136180880 501(C)(3) 400000 Research Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501(C)(3) 89645 Screening Baylor College Medicine Grants - Accounts Receivable Houston TX 770303411 741613878 501(C)(3) 2631365 Research Beth Israel Deaconess Medical Center Research Finance Office BR109 Boston MA 02215 042103881 501(C)(3) 78000 Research Boat People SOS 6066 Leesburg Pike 100 Falls Church VA 220412220 541563619 501(C)(3) 94357 Education Boston University 580 Harrison Avenue 3-W Boston MA 02118 042103547 501(C)(3) 135000 Research Breast Care for Washington 4 Atlantic St SW Washington DC 20032 455574713 501(C)(3) 90000 Screening Brigham & Women's Hospital PO Box 3149 Boston MA 022413149 042312909 501(C)(3) 497294 Research Broad Institute Inc 415 Main Street Cambridge MA 02142 263428781 501(C)(3) 360000 Research Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501(C)(3) 1460000 Treatment Cancer Resource Centers of Mendocino Cty 45040 Calpella Street Mendocino CA 95460 680357416 501(C)(3) 52430 Education Capital Breast Care Center 3970 Reservoir Road NW Washington DC 200571468 530196603 501(C)(3) 100000 Education CASA of Maryland Inc Attn Jennifer Freedman Hyattsville MD 20783 521372972 501(C)(3) 90000 Education Case Western Reserve University Controllers Office Cleveland OH 441067006 341018992 501(C)(3) 270000 Research Cedars Sinai Medical Center Attn Joanne Lazzaro Los Angeles CA 90048 951644600 501(C)(3) 75000 Research Children's Hospital Boston Research Finance Boston MA 022414413 042774441 501(C)(3) 120000 Research Cincinnati Children's Hospital Medical 3333 Burnet Avenue ML 7030 Cincinnati OH 45229 310833936 501(C)(3) 30000 Research Cold Spring Harbor Laboratory Attn Walter Goldschmidts Cold Spring Harbor NY 11724 112013303 501(C)(3) 180000 Research Columbia University Medical Center 722 West 168th Street 4th Floor New York NY 10032 135598093 501(C)(3) 582000 Research Cornell University Attn Ilene Lambiase Ithaca NY 14850 150532082 501(C)(3) 60000 Research Dana Farber Cancer Institute 44 Binney Street Mail Stop 439C Boston MA 02115 042263040 501(C)(3) 2308189 Research Doctors Community Hospital 8118 Good Luck Road Lanham MD 207063502 521638026 501(C)(3) 675000 Education, Screening Treatment Duke University Medical Center PO Box 602651 Charlotte NC 282602651 560532129 501(C)(3) 974979 Research Eastern Michigan University Attn Susan Shipley Ypsilanti MI 48197 382953297 501(C)(3) 45223 Education ECOG Research and Education Foundation 1818 Market Street Philadelphia PA 19109 391723095 501(C)(3) 100000 Research Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd W 373 Tampa FL 33647 650927702 501(C)(3) 24000 Education Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232003072 501(C)(3) 30000 Research Fred Hutchinson Cancer Research Center PO Box 19024 Mailstop J6-330 Seattle WA 981091024 563744111 501(C)(3) 260000 Research Friends of Cancer Research Attn Heather S Chaney Washington DC 20036 521983273 501(C)(3) 14000 Research George Washington University Grants and Contracts Accounting Svc Ashburn VA 20147 530196584 501(C)(3) 49615 Education Georgetown U Attn Jemas Reisert Washington DC 200571164 530196603 501(C)(3) 27000 Research H Lee Moffitt Cancer Center 12902 Magnolia Drive Tampa FL 33612 593238636 501(C)(3) 210000 Research Harvard Medical School Holyoke Center Room 600 Cambridge MA 02138 042103580 501(C)(3) 73000 Research Harvard University 25 Shattuck Street Sponsored Prgms Boston MA 02115 042103580 501(C)(3) 240000 Research Henry Ford Health System One Ford Place 5E Detroit MI 48202 381357020 501(C)(3) 140439 Research Holy Cross Hospital Attn Anne Gillis Silver Spring MD 20910 590791028 501(C)(3) 80000 Education Hudson-Alpha Institute for Biotechnology 601 Genome Way Huntsville AL 35801 432059317 501(C)(3) 282581 Research Indiana University (Indianapolis) Financial Mgmt Svcs PO Box 66057 Indianapolis IN 462666057 356001673 501(C)(3) 1485792 Research Johns Hopkins University 1101 E 33rd Street Suite C210 Baltimore MD 21218 520595110 501(C)(3) 1239925 Research Korean Community Svc Ctr of Greater WA Attn Jai Hoon Jung Annandale VA 22003 386005984 501(C)(3) 90000 Education Leland Stanford Jr University 3145 Porter Drive Palo Alto CA 94304 941156365 501(C)(3) 824898 Research Living Beyond Breast Cancer Attn Jean Sachs CEO Haverford PA 19041 530196932 501(C)(3) 65000 Education, Research Maasai Wildernes Conservation Fund PO Box 1413 Santa Barbara CA 93102 541943145 501(C)(3) 75000 Education Maryland Dept of Health & Mental Hygien 201 West Preston Street Room 303 Baltimore MD 21201 526002033 501(C)(3) 62372 Screening Mary's Ctr for Maternal&Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501(C)(3) 74747 Education, Screening, Treatment Massachusetts General Hospital PO Box 414876 Boston MA 022414876 042697983 501(C)(3) 586341 Research Mayo Clinic Jacksonville Griffin Building Room 170 Jacksonville FL 32224 593337028 501(C)(3) 100000 Research Mayo Clinic Rochester dba Mayo Clinic College of Medicine Rochester MN 559034008 416011702 501(C)(3) 96000 Research Medical University of South Carolina 171 Ashley Avenue Charleston SC 29425 576000722 501(C)(3) 240000 Research Memorial Sloan-Kettering Cancer Ctr 633 3rd Avenue 28th Floor New York NY 10017 131924236 501(C)(3) 120000 Research Metropolitan Chicago Breast Cancer 1645 W Jackson Blvd Ste 450 Chicago IL 606123244 262264895 501(C)(3) 400000 Education, Research MidMichigan Medical Center-Gratiot 300 East Warwick Drive Alma MI 48801 381437919 501(C)(3) 86110 Education Mobile Medical Care Inc 9309 Old Georgetown Road Bethesda MD 208141620 237022588 501(C)(3) 264745 Education, Screening Mount Sinai School of Medicine 633 Third Avenue New York NY 10017 136171197 501(C)(3) 120000 Research National Academy of Sciences 730 15th Street NW Washington DC 20005 530196932 501(C)(3) 13500 Research Neighborhood Health 6677 Richmond Highway Alexandria VA 22306 541849891 501(C)(3) 170689 Education, Screening, Treatment New York University School of Med General Accounting/Accounts Receiva New York NY 10016 135562308 501(C)(3) 150000 Research North Carolina Central University 1801 Fayetteville Street Durham NC 27707 566000730 501(C)(3) 135000 Research Northwestern University - Chicago 633 Clark Evanston IL 60208 362167817 501(C)(3) 302386 Research Nueva Vida Inc 2000 P Street NW Suite 300 Washington DC 20036 541943145 501(C)(3) 80000 Education Obesity Society 8757 Georgia Avenue Silver Spring MD 20910 541438429 501(C)(3) 9481 Research Ohio State Univ Research Foundation Finance Procurement Columbus OH 432101063 316025986 501(C)(3) 210000 Research Oregon Health & Science University Sponsored Program Admin Portland OR 97239 752668014 501(C)(3) 922441 Research Pangaea Global AIDS 436 14th Street Suite 920 Oakland CA 94612 912167423 501(C)(3) 50000 Education Partners for Cancer Care and Prevention 10 East Lee Street Unit 1901 Baltimore MD 21202 451605551 501(C)(3) 82500 Education Patient Advocate Foundation 421 Butler Farm Road Hampton VA 23666 830292601 501(C)(3) 475000 Treatment Pennsylvania State Univ College of Medi Controllers Office Hershey PA 17033 246000376 501(C)(3) 51929 Research Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22209 521429544 501(C)(3) 90000 Education Primary Care Coalition-MontgomeryCty Inc 8757 Georgia Avenue 10th Floor Silver Spring MD 20910 521847976 501(C)(3) 250000 Screening, Treatment Prince William Hospital 8700 Sudley Road Manassas VA 20110 541307595 501(C)(3) 186295 Education, Screening Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(C)(3) 260000 Research Program for Appropriate PO Box 900922 Seattle WA 98109 911157127 501(C)(3) 111290 Education Providence Health Foundation 1150 Varnum Street NE Washington DC 20017 521275583 501(C)(3) 78843 Education Providence Portland Medical Center 4805 NE Glisan St 5F40 Portland OR 97213 930386906 501(C)(3) 150000 Research Quantum Leap HealthCare Collaborative 3450 California Street San Francisco CA 941181837 204284925 501(C)(3) 8000 Education Regents of University of Michigan Room 7110 CCGC Internal Med Ann Arbor MI 481091274 746000949 501(C)(3) 138896 Research Research Advocacy Network 6505 West Park Boulevard Plano TX 75093 566001393 501(C)(3) 54916 Research Rockefeller University Attn Shawn Davis Ofc of Developme New York NY 10065 131624158 501(C)(3) 150000 Research Smith Farm Center for Healing & the Arts 1632 U Street NW Washington DC 20009 590624458 501(C)(3) 457500 Education, Screening, Treatment Society for Surgical Oncology 85 W Algonquin Road Arlington Heights IL 60005 136161070 501(C)(3) 30200 Research South East Alaska 3100 Channel Drive Juneau AK 99801 920056274 501(C)(3) 21250 Screening St Joseph Medical Center 2500 Bernville Road Reading PA 196030316 530196617 501(C)(3) 69027 Education Stanford University' PO Box 44253 San Francisco CA 941444253 941156365 501(C)(3) 260000 Research Stevens Institute of Technology 1 Castle Point Terrace Hoboken NJ 07030 221487354 501(C)(3) 60000 Research Supporting Our Sisters International In 2604 Pinebrook Ave C2 Hyattsville MD 20785 472511778 501(C)(3) 12500 Education The Ohio State University College Attn Kathy Milem Columbus OH 43205 316025986 501(C)(3) 135000 Research The Red Devils Attn Janice Wilson Towson MD 21286 743070929 501(C)(3) 20871 Treatment The Salk Institute Attn Christine Marckese La Jolla CA 920371002 376000511 501(C)(3) 160000 Research The University of Chicago 5801 South Ellis Avenue Chicago IL 60637 362177139 501(C)(3) 373239 Research The Vanderbilt University PMB 406310 Nashville TN 372406310 620476822 501(C)(3) 108000 Research Thomas Jefferson University Scott Bldg Room 528 Philadelphia PA 191075587 232829095 501(C)(3) 75000 Research Trustees of Columbia Univ Sponsored Projects Finance New York NY 10027 135598093 501(C)(3) 40886 Research Trustees of Dartmouth College Office of Sponsored Projects Hanover NH 037551404 020222111 501(C)(3) 150000 Research Tulane University Health Sciences Center 800 E Commerce Harahan LA 70023 720423889 501(C)(3) 120000 Research Univ of North Carolina at Chapel Hill 104 Airport Drive Suite 2200 CB Chapel Hill NC 275991350 566001393 501(C)(3) 1795346 Research Univ of TX MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501(C)(3) 750286 Research University Miami School of Medicine Attn Maria A Garcia Atlanta GA 303845803 590624458 501(C)(3) 150000 Research University of Alabama at Birmingham 1530 3rd Avenue South Birmingham AL 352940111 636005396 501(C)(3) 285000 Research University of Arizona Bursar/Sponsored Projects Tucson AZ 857334390 742652689 501(C)(3) 270000 Research University of California at San Diego 9500 Gilman Drive MC 0009 La Jolla CA 92093 956006144 501(C)(3) 9664 Research University of California-Davis Cashiers Office West Sacramento CA 957989062 946036494 501(C)(3) 59855 Research University of California-Los Angeles Administrative Main Cashier Ofc Los Angeles CA 900959000 956006143 501(C)(3) 310000 Research University of California-San Diego UCSD Cashiers Office La Jolla CA 92093 956006144 501(C)(3) 150000 Research University of California-San Francisco 1600 Divisadero St Box 1710 San Francisco CA 94115 946036493 501(C)(3) 683848 Research University of Cincinnati 51 Goodman Dr Univ Hall Suite 5 Cincinnati OH 452210222 316000989 501(C)(3) 150000 Research University of Delaware 30 Lovett Aenue Newark DE 19716 516000279 501(C)(3) 150000 Research University of Illinois at Chicago 809 S Marshfield Avenue MC551 Chicago IL 606081264 376000511 501(C)(3) 108000 Research University of Illinois--Urbana-Champaign Grants Contracts-Post Award Springfield IL 627084610 376000511 501(C)(3) 60000 Research University of Kansas Medical Center Attn Tim Siskey Kansas City KS 66160 481108830 501(C)(3) 838050 Research University of Massachusetts Amherst Goodell Bldg Room 405 Amherst MA 010033210 043167352 501(C)(3) 148996 Research University of Miami School of Medicine Center for Cancer Prevention and Ge Miami FL 33136 590624458 501(C)(3) 67500 Education, Research University of Michigan Alexandra Thebaud Ann Arbor MI 481091274 386006309 501(C)(3) 662807 Research University of Michigan Health Systems 3003 S State St Rm 1054 Ann Arbor MI 481091274 386006309 501(C)(3) 160000 Research University of Minnesota McNamara Alumni Center Minneapolis MN 554552070 416007513 501(C)(3) 197637 Research University of Notre Dame du Lac 731 Grace Hall Notre Dame IL 46556 350868188 501(C)(3) 120000 Research University of Pennsylvania Office of Research Services Philadelphia PA 191046205 231352685 501(C)(3) 1180618 Education, Research University of Pittsburgh 350 Thackeray Hall Pittsburgh PA 15260 250966691 501(C)(3) 464600 Research University of Southern California Attn Robert Osuna Los Angeles CA 900898001 951642394 501(C)(3) 392759 Research University of Texas at Health Science Ce Elizabeth Frantz Houston TX 77030 741587488 501(C)(3) 135000 Research University of Utah 201 South Presidents Circle Room Salt Lake City UT 841129020 876000525 501(C)(3) 226316 Research University of Washington Attn Tami Sadusky Seattle WA 98105 916001537 501(C)(3) 571999 Research University of Wisconsin - Madison Research Sponsored Programs Madison WI 537151218 396006492 501(C)(3) 149760 Research UT HSC - San Antonio Office of Sponsored Programs San Antonio TX 772293900 741586031 501(C)(3) 405075 Research UT Southwestern Medical Center UT Southwestern Grants Mgmt Dallas TX 752841753 746000203 501(C)(3) 162000 Research UTMD Anderson Cancer Ctr 1515 Holcombe Boulevard Unit 1644 Houston TX 770304009 746001118 501(C)(3) 652089 Research Vanderbilt University Medical Center 1161 21st Avenue South Nashville TN 372325545 620476822 501(C)(3) 544894 Research Vermont Cancer Ctr UVM College of Med Attn Jennifer Gagnon Burlington VT 05405 030179440 501(C)(3) 345000 Research Vietnamese Resettlement Association Inc Attn Kim O Cook Falls Church VA 22044 541512549 501(C)(3) 129703 Education, Screening, Treatment Virginia Commonwealth University Attn Mark Roberts Richmond VA 232843038 546001758 501(C)(3) 168515 Research Washington Univ at St Louis 700 Rosedale Ave Campus Box 1034 St Louis MO 63112 430653611 501(C)(3) 1930597 Research Wayne State University Sponsored Program Admin Detroit MI 48202 366028429 501(C)(3) 361303 Research Whitehead Inst for Biomedical Research 9 Cambridge Center Cambridge MA 021421479 061043412 501(C)(3) 100000 Research Whitman-Walker Clinic 1701 14th Street NW Washington DC 20009 521122122 501(C)(3) 97068 Education, Treatment Winchester Medical Center Foundation 1840 Amherst Street Winchester VA 22601 542013319 501(C)(3) 32503 Screening Yale University 2 Whitney Avenue New Haven CT 06510 060646973 501(C)(3) 100000 Research Young Survival Coalition Lori Atkinson New York NY 10006 134057685 501(C)(3) 65000 Education 144 Procedures for Monitoring the use of grants Schedule I Part 1 Line 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D. - LEVEL RESEARCH GRANT MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY A MASTER'S or PH.D. LEVEL COMMUNITY OR GLOBAL GRANTS MANAGER. EACH YEAR OF THE GRANT TERM, THE GRANTEE IS REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, CHALLENGES ENCOUNTERED, AND A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) WITH WRITTEN JUSTIFICATION. AS APPROPRIATE THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH THE GRANTEE TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL OF KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM. X true true X X X X X X false false false false false false false false false Robert Green Chief Financial Officer 260569 65000 4284 1435 4520 335808 Dr Judith Salerno President & CEO (End 11/16) 524167 21021 4089 15771 565048 Ellen Willmott beg 1116 secretary and Interim Pres/CEO 286375 2802 11970 15817 316964 Lesley Lurie Deputy Counsel & Asst. SEC 219310 2667 23449 13592 259018 Christina Alford SVP, Development 279204 2740 740 5157 287841 Victoria Wolodzko VP Research & Community Health 181767 2430 8712 10953 203862 Lori Maris SVP, Affl Network (Beg 1/17) 146654 2920 8496 7343 165413 Miguel Perez SVP, AFFLT NTWK (END 01/17) 204616 3230 14044 11184 233074 Charlotte Walsh SVP Marketing (End 8/16) 174270 787 17778 192835 Eric Montgomery VP, Information Technology 186702 2634 32912 10577 232825 Catherine Olivieri VP, Human Resources 208122 2802 34062 7449 252435 RIA WILLIAMS Controller 165042 2215 28927 10595 206779 Gary Cole Sr Dir, (End 12/16) 172355 578 18582 9643 201158 Andrea Rader Sr Dir, Communications 166998 2912 15489 10826 196225 Subhendu Rath Sr Dir, IT Enterprise Systems 157629 0 0 2198 0 23046 0 9809 0 192682 0 0 Vanessa Hewitt Sr Dir, Internal Audit 155157 0 0 633 0 14288 0 9678 0 179756 0 0 Form 990, Schedule J, Part I, Line 1A SUPPLEMENTAL COMPENSATION INFORMATION EXCEPT AS MAY BE APPROVED IN ADVANCE FOR MEDICAL ACCOMODATION, FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. X 1798 cost or sales price X 40970 cost or sales price X 110 15700 cost or sales price X ADVANTAGE MILES 800000 24000 COST OR SALES PRICE false true false VOLUNTEERS FORM 990, PART I, QUESTION 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART I, QUESTION 8 The primary cause of the decrease reported on Part I, line 8, for contributions and grants is due to Komen receiving a one-time restricted donation during fiscal year 2016 of approximately $40 million. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, FUNDING MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $956 MILLION IN BREAST CANCER RESEARCH AND PROVIDED OVER $2 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 30 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE DESIGNED TO UNDERSTAND THE BIOLOGY OF BREAST CANCER AND ADVANCE THE TRANSLATION OF RESEARCH BREAKTHROUGHS INTO NEW WAYS TO DETECT, DIAGNOSE, TREAT, AND PREVENT BREAST CANCER, AND KOMENS BOLD GOAL TO REDUCE THE CURRENT NUMBER OF BREAST CANCER DEATHS BY 50 PERCENT IN THE U.S. BY 2026. KOMEN IS GUIDED IN SETTING ITS RESEARCH STRATEGY BY A SCIENTIFIC ADVISORY BOARD, A GROUP OF INTERNATIONALLY RECOGNIZED DOCTORS, SCIENTISTS AND ADVOCATES, AND CONSULTS WITH THE KOMEN SCHOLARS, A GROUP COMPRISED OF DOCTORS, SCIENTISTS, AND PATIENT ADVOCATES NOTED FOR THEIR ACCOMPLISHMENTS IN BREAST CANCER RESEARCH AND ADVOCACY. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY17, KOMEN AWARDED MORE THAN 100 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, CANADA, FRANCE, ITALY, AND THE NETHERLANDS. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, THE PUBLIC CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS DUE TO A LACK OF FUNDING OPPORTUNITIES. TO THAT END, KOMEN AWARDED POSTDOCTORAL FELLOWSHIPS, GRADUATE TRAINING IN DISPARITIES RESEARCH GRANTS, AND CAREER CATALYST RESEARCH GRANTS (WITH A COMPETITIVE RENEWAL OPTION) TO SUPPORT YOUNG INVESTIGATORS IN BREAST CANCER RESEARCH. EACH MECHANISM IS FURTHER DESCRIBED BELOW: POSTDOCTORAL FELLOWSHIPS (PDF): PDF GRANTS SEEK TO ATTRACT AND SUPPORT PROMISING SCIENTISTS EMBARKING ON CAREERS DEDICATED TO BREAST CANCER RESEARCH WHO HAVE NO MORE THAN 3 YEARS POST-COMPLETION OF THEIR MOST RECENT CLINICAL FELLOWSHIP, 5 YEARS POST-COMPLETION OF THEIR MOST RECENT RESIDENCY (FOR PHYSICIANS) OR 5 YEARS POST-COMPLETION OF THEIR MOST RECENT PHD. BY PROVIDING FUNDING TO OUTSTANDING POSTDOCTORAL/POSTGRADUATE FELLOWS UNDER THE GUIDANCE OF A MENTOR, KOMEN SEEKS TO ENSURE THAT A DIVERSE POOL OF HIGHLY TRAINED SCIENTISTS WILL EMERGE AS THE NEXT GENERATION OF LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. PDF GRANTS PROVIDE SUPPORT FOR RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. GRADUATE TRAINING IN DISPARITIES RESEARCH GRANTS (GTDR): GTDR GRANTS ARE INTENDED TO ESTABLISH AND/OR TO SUSTAIN A TRAINING PROGRAM DEDICATED TO UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES ACROSS POPULATION GROUPS. AT LEAST THREE GRADUATE STUDENTS, PREFERABLY THOSE FROM POPULATIONS AFFECTED BY DISPARITIES IN BREAST CANCER OUTCOMES, ARE SUPPORTED. CAREER CATALYST RESEARCH GRANTS (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN 6 YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. CCR GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. KOMEN ALSO OFFERS RESEARCH GRANTS THAT SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, ESPECIALLY AT A TIME OF DIMINISHING FEDERAL FUNDING FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. CAREER CATALYST RESEARCH GRANTS-COMPETING RENEWALS (CCR-CR): CCR-CR GRANTS WERE DESIGNED TO ADDRESS THE INTENSE COMPETITION AND LACK OF FUNDING THAT MAY CAUSE TALENTED YOUNG SCIENTISTS TO LEAVE THE FIELD. CCR-CR GRANT ARE INTENDED TO PROVIDE CONTINUED SUPPORT TO EARLY CAREER BREAST CANCER RESEARCHERS AND CLINICIAN-SCIENTISTS WHO HAVE HAD PRIOR KOMEN CCR GRANT SUPPORT, BUT HAVE NOT YET SECURED SUPPORT AS A PRINCIPAL INVESTIGATOR THROUGH A NATIONAL INSTITUTES OF HEALTH R01 AWARD OR OTHER INDEPENDENT AWARD SIMILAR IN SCOPE. IT IS EXPECTED THAT AWARDEES WILL LEVERAGE THE CCR-CR AWARD TO SUCCESSFULLY COMPETE FOR ADDITIONAL INDEPENDENT RESEARCH FUNDING IN BREAST CANCER, AND THUS REMAIN IN THE FIELD. INFLAMMATORY BREAST CANCER RESEARCH INNOVATOR GRANTS (IBC): GENEROUSLY SUPPORTED BY THE MILBURN FOUNDATION AND THE INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, THESE INNOVATOR GRANTS ARE INTENDED TO SPUR IDEAS THAT WILL INCREASE THE UNDERSTANDING OF HOW IBC CAN BE BETTER DIAGNOSED AND HOW BIOLOGY DRIVES ITS PROGRESSION, THEREBY LEADING TO IMPROVED PROGNOSIS AND MORE EFFECTIVE TREATMENTS FOR THOSE WITH THIS AGGRESSIVE DISEASE. THIS PROGRAM CONSISTS OF TWO STAGES. IN THE FIRST STAGE, ONE YEAR OF FUNDING IS AWARDED TO ALLOW INVESTIGATORS TO ESTABLISH THE FOUNDATION OF A ROBUST AND INNOVATIVE IBC RESEARCH PROJECT. IN THE SECOND STAGE, AWARDEES WILL HAVE THE OPPORTUNITY TO COMPETE FOR ADDITIONAL FUNDING TO BUILD UPON THEIR ORIGINAL PROJECT. LEADERSHIP GRANTS LEADERSHIP GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS CONDUCTED BY THE DISTINGUISHED BREAST CANCER RESEARCHERS AND CLINICIANS WHO SERVE AS KOMENS MISSION ADVISORS AND SEEK TO DISCOVER AND DELIVER THE CURES FOR BREAST CANCER. OPPORTUNITY GRANTS / STRATEGIC PARTNERSHIP AND PROGRAM GRANTS (OG/SPP) OG AND SPP GRANTS SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, ESPECIALLY AT A TIME OF DIMINISHING FEDERAL FUNDING FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. KOMEN'S RESEARCH INVESTMENT THROUGH THESE GRANT MECHANISMS SUPPORTS PROJECTS THAT AIM TO, AMONG OTHER THINGS: (A) DEVELOP TARGETED THERAPIES; (B) OVERCOME BREAST CANCER PROGRESSION AND METASTASIS; (C) PREDICT RISK; (D) IMPROVE DIAGNOSIS MONITORING, AND TREATMENT OF AGGRESSIVE TYPE OF BREAST CANCER; (E) OVERCOME TREATMENT RESISTANCE; (F) DEVELOP NEW IMAGING TECHNIQUES; AND (G) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES. EXAMPLES OF THESE GRANTS COMMITTED IN FY17 INCLUDE: A) TARGETED THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER: DANIEL STOVER, M.D. FROM DANA-FARBER CANCER INSTITUTE WAS AWARDED A CAREER CATALYST RESEARCH GRANT. HE WILL STUDY PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER (TNBC) WHOSE CANCER HAS SPREAD TO OTHER PARTS OF THE BODY, FOCUSING HIS STUDIES TO DETERMINE THE GENOMIC ALTERATIONS THAT CONTRIBUTE TO EARLY RESISTANCE TO THERAPY IN THESE PATIENTS. ULTIMATELY, THESE STUDIES COULD LEAD TO THE DEVELOPMENT OF NEW TREATMENTS TO OVERCOME THIS RESISTANCE, LEADING TO IMPROVED OUTCOMES IN PATIENTS DIAGNOSED WITH TNBC. B) UNDERSTAND BREAST CANCER PROGRESSION AND METASTASIS: KOMEN SCHOLAR ADRIAN LEE, PH.D. FROM THE UNIVERSITY OF PITTSBURGH WAS AWARDED A LEADERSHIP GRANT. DR. LEE WILL CONTINUE HIS RESEARCH ON A SPECIFIC MUTATION IN BRAIN METASTASES, DETERMINE THE SIGNIFICANCE OF MOLECULAR CHANGES. AND IDENTIFY NEW THERAPEUTIC TARGETS AND TREATMENTS. C) PREDICT RISK: KOMEN SCHOLAR SUSAN DOMCHEK, M.D. FROM THE UNIVERSITY OF PENNSYLVANIA WAS AWARDED A LEADERSHIP GRANT. SHE WILL CONTINUE HER WORK CREATING A REGISTRY TO FOLLOW INDIVIDUALS THAT HAVE HAD GENETIC TESTING AND TESTED POSITIVE FOR KNOWN BREAST CANCER MUTATIONS OR MUTATIONS ASSOCIATED WITH UNKNOWN RISK. THE REGISTRY WILL PROVIDE CRITICAL INFORMATION TO IDENTIFY THOSE AT RISK OF BREAST CANCER AND HELP RESEARCHERS IMPROVE THEIR UNDERSTANDING OF THE RISKS ASSOCIATED WITH DIFFERENT MUTATIONS, WHICH COULD IMPROVE OUTCOMES AMONG THESE INDIVIDUALS. D) IMPROVE DIAGNOSIS, MONITORING, AND TREATMENT OF INFLAMMATORY BREAST CANCER: IN PARTNERSHIP WITH THE MILBURN FOUNDATION AND THE INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, MIHAELA SKOBE, PH.D. FROM THE ICAHN SCHOLL OF MEDICINE AT MOUNT SINAI WAS AWARDED AN INFLAMMATORY BREAST CANCER INNOVATOR GRANT. HER WORK WILL FOCUS ON UNDERSTANDING HOW THE INTERACTIONS BETWEEN TRIPLE NEGATIVE INFLAMMATORY BREAST CANCER AND THE LYMPHATIC SYSTEM INFLUENCE THE AGGRESSIVENESS OF THE DISEASE, ULTIMATELY PROVIDING INSIGHT ON POTENTIAL NEW TREATMENT STRATEGIES. E) IMPROVE TREATMENT RESPONSE: CARMEN BERGOM, M.D., PH.D., FROM THE MEDICAL COLLEGE OF WISCONSIN WAS AWARDED A CAREER CATALYST RESEARCH GRANT TO IDENTIFY TUMOR MICROENVIRONMENT GENES THAT CHANGE THE ABILITY OF RADIATION THERAPY TO BE AN EFFECTIVE TREATMENT. ONCE IDENTIFIED, THESE GENES COULD BE TARGETED TO IMPROVE RADIATION THERAPY TREATMENT RESPONSES AND ULTIMATELY IMPROVE PATIENT SURVIVAL. F) DEVELOP NEW IMAGING TECHNIQUES: KOMEN SCHOLAR ELIZABETH MORRIS, M.D. FROM MEMORIAL SLOAN-KETTERING CANCER CENTER WAS AWARDED A LEADERSHIP GRANT. HER WORK WILL COMBINE GENOMIC MUTATION INFORMATION WITH MRI IMAGING TO IDENTIFY NEW BREAST MRI BIOMARKERS TO BE TESTED IN A CLINICAL TRIAL. THE DEVELOPMENT OF NEW PREDICTIVE AND PROGNOSTIC MRI BIOMARKERS MAY HELP TO BETTER PREDICT TREATMENT RESPONSES AND IMPROVE PATIENT OUTCOMES. G) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES: LORNA MCNEIL, PH.D., AND KELLY HUNT, M.D., FROM THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER WERE AWARDED A GRADUATE TRAINING IN DISPARITIES RESEARCH GRANT. WITH KOMENS SUPPORT THEY WILL CREATE THE MD ANDERSON TRAINING PROGRAM TO REDUCE BREAST CANCER DISPARITIES IN BLACK AND HISPANIC WOMEN. GRADUATE STUDENTS WILL COMBINE COURSEWORK WITH INDIVIDUALLY-TAILORED RESEARCH PROJECTS AND INTERACTIVE COMMUNITY BASED AND CLINICAL BREAST CANCER EXPERIENCES TO DEVELOP NOVEL STRATEGIES TO IMPROVE THE LIVES OF AFRICAN AMERICAN AND HISPANIC WOMEN WITH AND AT RISK FOR BREAST CANCER. EDUCATION AND PATIENT SUPPORT KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE, AS WELL AS INFORMATION ABOUT OUR RESEARCH PROGRAMS, COMMUNITY PROGRAMS, VOLUNTEER OPPORTUNITIES AND EVENTS. THE "ABOUT BREAST CANCER" SECTION OF KOMENS WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER STAFF, RECEIVED NEARLY SEVEN MILLION PAGE VIEWS DURING FY17. KOMEN ALSO PRODUCES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS. KOMEN AND ITS AFFILIATES, GRANTEES AND OTHERS DISTRIBUTED MORE THAN 1.6 MILLION EDUCATIONAL MATERIALS IN FY17. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH AND FOR BLACK AND AFRICAN-AMERICAN COMMUNITIES. THE SUSAN G. KOMEN "1-877 GO KOMEN" (1-877-465-6636) BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES FOR PATIENTS, FAMILIES, AND FRIENDS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. ET. DURING FY17, THE KOMEN BREAST CANCER HELPLINE RESPONDED TO MORE THAN 12,000 CALLS AND EMAILS. IN ADDITION, IN FY17 KOMEN SUPPORTED TWO NON-PROFIT ADVOCACY ORGANIZATIONS TO PRESENT PATIENT-FOCUSED, EDUCATIONAL CONFERENCES DEDICATED TO THE CRITICAL ISSUES FACING BREAST CANCER PATIENTS AND THEIR FAMILIES. KOMEN'S FUNDING OF LIVING BEYOND BREAST CANCER'S (LBBC) ANNUAL CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER AND THE YOUNG SURVIVAL COALITION'S (YSC'S) NATIONAL SUMMIT FOR YOUNG WOMEN AFFECTED BY BREAST CANCER GAVE APPROXIMATELY 1,200 SURVIVORS AND CO-SURVIVORS A CHANCE TO CONNECT WITH EACH OTHER WHILE ALSO HEARING FROM LEADING RESEARCHERS ABOUT THE LATEST ADVANCES IN BREAST CANCER CARE. BREAST CANCER IS THE MOST COMMON CANCER IN WOMEN, WORLDWIDE, AND THE NUMBER OF CASES IS INCREASING IN NEARLY EVERY COUNTRY. THE NUMBER OF NEW BREAST CANCER CASES HAS MORE THAN DOUBLED AROUND THE WORLD IN THE LAST THREE DECADES, WITH HIGHEST INCREASES OBSERVED IN LOW AND MIDDLE INCOME COUNTRIES. BREAST CANCER IS ALSO THE LEADING CAUSE OF CANCER DEATH IN THESE COUNTRIES, WITH OVER 500,000 DEATHS IN 2012. THESE TRENDS ARE CONCERNING, WHICH IS WHY KOMEN WORKS TIRELESSLY TO PROVIDE SUPPORT TO BREAST HEALTH PROGRAMS WORLDWIDE. IT TAKES COLLABORATION AND STRONG PARTERNSHIPS TO MAKE A GLOBAL IMPACT. KOMEN STRIVES TO SERVE AS A "BRIDGE" COLLABORATING WITH INTERNATIONAL NONPROFITS, CORPORATIONS, AND MINISTRIES OF HEALTH TO BRING TOGETHER PEOPLE AND ORGANIZATIONS TO DEVELOP PROGRAMS THAT ARE TAILORED TO THE SPECIFIC NEEDS OF THE COMMUNITY AND SENSITIVE TO CULTURAL DIFFERENCES. IN FY17, KOMENS GLOBAL PROGRAM AWARDED EIGHT GRANTS TO SUPPORT EDUCATION PROGRAMMING FOR PATIENTS AND FOR HEALTH PROFESSIONALS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN BOSNIA & HERZEGOVINA, BRAZIL, HUNGARY, ISRAEL, MEXICO, PANAMA. IN BOSNIA & HERZEGOVINA AND HUNGARY, THE AMERICAN JEWISH JOINT DISTRIBUTION COMMITTEE (JDC) AND LOCAL PARTNERS SUPPORT THE EARLY DETECTION OF BREAST CANCER ULTIMATELY AIMING TO REDUCE BREAST CANCER MORTALITY RATES, PARTICULARLY AMONG MINORITY AND HIGHER-RISK POPULATIONS, BY SUPPORTING BREAST HEALTH AND CANCER EDUCATION SESSIONS, SCREENING ACTIVITIES, AND HEALTH PROVIDER SCREENING TRAININGS, TO IMPROVE ACCESS TO TIMELY AND QUALITY CARE. ADVOCACY SUSAN G. KOMEN IS THE VOICE FOR THE MORE THAN 3.1 MILLION BREAST CANCER SURVIVORS AND THOSE WHO LOVE THEM. KOMEN WORKS TO ENSURE THAT THE FIGHT AGAINST BREAST CANCER IS A PRIORITY AMONG POLICYMAKERS IN WASHINGTON, D.C., AND EVERY STATE CAPITOL ACROSS THE COUNTRY. EACH YEAR, THROUGH A TRANSPARENT, BROAD-BASED AND INTENSIVE VETTING AND SELECTION PROCESS, KOMEN WORKS TO IDENTIFY THE POLICY ISSUES WITH THE GREATEST POTENTIAL MISSON IMPACT. THIS PROCESS INCLUDES COLLECTING FEEDBACK FROM KOMEN HEADQUARTERS' LEADERSHIP, POLICY STAFF, AND SUBJECT MATTER EXPERTS; KOMEN AFFILIATES FROM ACROSS THE COUNTRY; ADVISORY GROUPS INCLUDING THE KOMEN ADVOCACY ADVISORY TASKFORCE (KAAT), ADVOCATES IN SCIENCE (AIS), AND KOMEN SCHOLARS; AND OTHER STAKEHOLDERS WITH A VESTED INTEREST IN BREAST CANCER-RELATED ISSUES. THE SELECTED ISSUES ARE THE BASIS FOR KOMEN'S STATE AND FEDERAL ADVOCACY WORK IN THE COMING YEAR. KOMEN'S 2017 ADVOCACY PRIORITIES INCLUDED: SUPPORTING EXPANDED FEDERAL FUNDING FOR BREAST CANCER RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE DEPARTMENT OF DEFENSE (DOD); SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC MAMMOGRAPHY; AND EVALUATING STATE AND FEDERAL POLICIES TO INCREASE PUBLIC ACCESS TO INFORMATION ABOUT AND PARTICIPATION IN CLINICAL TRIALS FOR ALL PATIENT POPULATIONS. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR 2015 AND 2016 ADVOCACY PRIORITIES, KOMEN ALSO ENGAGED ON ISSUES RELATED TO BREAST DENSITY, COMPASSIONATE USE, GENETIC TESTING, HEALTH DISPARITIES, LYMPHEDEMA, METASTATIC BREAST CANCER, NETWORK ADEQUACY, PALLIATIVE CARE AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES AND ADDITIONAL POLICY AREAS TO FURTHER KOMEN'S MISSION OF ENDING BREAST CANCER FOREVER. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK. SCREENING AND PATIENT NAVIGATION GETTING REGULAR SCREENING TESTS, ALONG WITH EFFECTIVE AND QUALITY TREATMENT IF DIAGNOSED, LOWERS THE RISK OF DYING FROM BREAST CANCER. SCREENING TESTS CAN FIND BREAST CANCER EARLY, WHEN CHANCES FOR SURVIVAL ARE HIGHEST. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE. EVIDENCE SHOWS NAVIGATION IMPROVES ADHERENCE TO SCREENING RECOMMENDATIONS, AND THUS IMPROVES OVERALL OUTCOMES. KOMEN SUPPORTS FREE AND LOW-COST SCREENING PROGRAMS IN UNDERSERVED COMMUNITIES THAT HELP NAVIGATE WOMEN TO QUALITY CARE, AND/OR PROVIDE COVERAGE FOR SCREENING SERVICES TO WOMEN WITHOUT HEALTH INSURANCE, OR THOSE WITH HIGH CO-PAYS AND DEDUCTIBLES THAT MAKE SCREENING TOO COSTLY. IN FY17, KOMEN AWARDED SCREENING COMMUNITY GRANTS TO TWO NON-PROFIT ORGANIZATIONS, WHICH REACH LOW-INCOME, MINORITY AND UNINSURED WOMEN IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7 AND 8, AND ALEXANDRIA CITY, VA., WHERE DEATH RATES FROM BREAST CANCER CONTINUE TO RANK ABOVE NATIONAL AVERAGES. THROUGH KOMEN SUPPORT, THE AFRICAN WOMENS CANCER AWARENESS ASSOCIATION WILL PROVIDE PATIENT NAVIGATION SERVICES FOR AFRICAN IMMIGRANT WOMEN TO LINK THEM TO CULTURALLY COMPETENT HEALTH AND SUPPORT SERVICES, ENSURING THEY RECEIVED ASSISTANCE AFTER AN ABNORMAL BREAST CANCER SCREENING RESULT AND BEFORE DIAGNOSIS. THROUGH ITS GLOBAL PROGRAM, KOMEN AWARDED TEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF SCREENING AND PATIENT NAVIGATION PROGRAMS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN BOSNIA & HERZEGOVINA, BRAZIL, HUNGARY, ISRAEL, MEXICO, PANAMA, AND TANZANIA. IN SUPPORT OF BREAST HEALTH SERVICES IN SERGIPE, BRAZIL, KOMEN FUNDED PROJECTS BUILD THE CAPACITY OF HEALTH PROFESSIONALS IN THREE AREAS: (1) FUNDAO PIO XII - HOSPITAL DE CNCER DE BARRETOS TO IMPROVE MAMMOGRAPHY QUALITY; (2) CENTRO DE ESTUDOS E PESQUISA DO HOSPITAL PEROLA BYINGTON TO REDUCE THE TIME FROM SCREENING TO DIAGNOSIS; AND (3) INSTITUTO ONCOGUIA TO PREPARE SOCIAL WORKERS ON PATIENT NAVIGATION AND PATIENT RIGHTS. TREATMENT AND PATIENT NAVIGATION BARRIERS TO QUALITY CARE ARE OFTEN ASSOCIATED WITH POOR BREAST CANCER OUTCOMES AND RESULTANT CANCER DISPARITIES AMONG SPECIFIC POPULATION GROUPS. THE MOST COMMON BARRIERS TO QUALITY CARE INCLUDE: (1) ABILITY TO PAY FOR CARE; (2) LANGUAGE/CULTURE; (3) COMMUNICATION; (4) LACK OF TRANSPORTATION; (4) BIAS; AND (5) FEAR. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM TO ENSURE TIMELY DIAGNOSIS AND TREATMENT. EVIDENCE SHOWS PATIENT NAVIGATION IMPROVES ADHERENCE TO TREATMENT RECOMMENDATIONS, RESULTING IN IMPROVED OUTCOMES. IN FY17, KOMEN FUNDED EIGHT NON-PROFIT ORGANIZATIONS IN SUPPORT OF PROGRAMS TO REDUCE STRUCTURAL, PERSONAL, SOCIOCULTURAL, AND FINANCIAL BARRIERS TO CARE, AND PROVIDE PATIENT NAVIGATION SERVICES FOR UNDERSERVED COMMUNITIES IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7, AND 8, AND ALEXANDRIA CITY, VA. NUEVA VIDA WILL USE GRANT FUNDS FROM KOMEN TO SERVE 100% MEDICALLY UNDERSERVED LATINOS AND PROVIDE CULTURALLY SENSITIVE AND APPROPRIATE PATIENT NAVIGATION SERVICES THROUGHOUT DIAGNOSIS, TREATMENT, SURVIVORSHIP, AND END OF LIFE. THROUGH ITS GLOBAL PROGRAM, KOMEN AWARDED SEVEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF TREATMENT AND PATIENT NAVIGATION PROGRAMS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN BOSNIA & HERZEGOVINA, BRAZIL, HUNGARY, ISRAEL, MEXICO, PANAMA, AND TANZANIA. IN FY17, KOMEN SUPPORTED CASITA DE MAUSI TO PROVIDE LODGING, TRANSPORTATION, AND MEALS FOR BREAST CANCER PATIENTS FROM RURAL COMMUNITIES IN PANAMA, FACILITATING THEIR ACCESS TO BREAST CANCER SERVICES. KOMENS TREATMENT ASSISTANCE FUND ADMINISTERED BY CANCERCARE AIMS TO HELP THOSE IN BREAST CANCER TREATMENT WHO ARE FACING FINANCIAL CHALLENGES BY PROVIDING LIMITED FINANCIAL ASSISTANCE, EDUCATION, AND SUPPORT SERVICES. FINANCIAL ASSISTANCE IS GRANTED TO LOW-INCOME, UNDERINSURED OR UNINSURED WOMEN ACROSS THE COUNTRY WHO MEET PRE-DETERMINED ELIGIBILITY CRITERIA. THIS PROGRAM PROVIDES FINANCIAL ASSISTANCE FOR TREATMENT-RELATED COSTS, INCLUDING BUT NOT LIMITED TO, TRANSPORTATION TO AND FROM TREATMENT, CHILD/ELDER CARE, HOME CARE, ORAL PAIN/ANTI-NAUSEA MEDICATIONS, ORAL CHEMOTHERAPY/HORMONE THERAPY, LYMPHEDEMA CARE/SUPPLIES, PALLIATIVE CARE, AND DURABLE MEDICAL EQUIPMENT. IN FY17, KOMEN AWARDED $1.7 MILLION IN CONTINUED SUPPORT OF THIS TREATMENT ASSISTANCE PROGRAM, WITH A GOAL TO SERVE MORE THAN 4,000 PATIENTS IN NEED. FOR MORE INFORMATION ABOUT ANY OF THE ACCOMPLISHMENTS DESCRIBED HERE OR TO LEARN MORE ABOUT SUSAN G. KOMEN, VISIT WWW.KOMEN.ORG OR CALL 1-877 GO KOMEN (1-877-465-6636). EXECUTIVE COMMITTEE FORM 990, PART VI, LINE 1A THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES. SIGNIFICANT CHANGES TO GOVERNING DOCUMENTS FORM 990, PART VI, QUESTION 4 SIGNIFICANT CHANGES DURING FISCAL YEAR 2017: INCREASED THE MINIMUM NUMBER OF MEMBERS ON THE GOVERNANCE COMMITTEE TO THREE (3) MEMBERS, TO INCLUDE THE CHAIR OF THE BOARD AND THE PRESIDENT & CHIEF EXECUTIVE OFFICER. REMOVED THE BOARD OF DIRECTORS AUTHORITY TO APPOINT/HIRE THE OPTIONAL OFFICER POSITIONS OF CHAIR OF GLOBAL STRATEGY, CHIEF MARKETING AND REVENUE OFFICER, AND CHIEF MISSION OFFICER . ADDED THE PRESIDENT & CHIEF EXECUTIVE OFFICER AS AN EX-OFFICIO, VOTING MEMBER OF THE GOVERNANCE COMMITTEE. DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING. DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING. DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTEREST FORM 990, PART VI, QUESTION 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARD MEMBERS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY REPORTED POTENTIAL OR ACTUAL CONFLICTS ARE THEN REVIEWED BY SENIOR MANAGEMENT AND THE AUDIT COMMITTEE, WHEREUPON APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARD MEMBERS ARE REQUIRED TO UPDATE THEIR RESPECTIVE CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. UPDATE THEIR RESPECTIVE CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. OFFICES & POSITION FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS BEGUN FORM 990, PART VI, QUESTIONS 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE PRESIDENT & CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE PRESIDENT & CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. FOR THE POSITIONS OF PRESIDENT & CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, AND SVP, DEVELOPMENT, EXTERNAL BENCHMARKING WAS CONDUCTED TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO GEN PUBLIC FORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST. ADDITNL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXP FORM 990, PART IX, LINE 24 KOMEN PAYS 80% OF THE COST OF ALL T-SHIRTS FOR THE SUSAN G. KOMEN RACE FOR THE CURE EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE YEAR. OTHER CHANGES IN NET ASSETS OR FUND BALANCES FORM 990, PART XI, LINE 9 RESCINDED GRANTS $6,673,343 NET DIRECT BENEFIT AFFILIATE RACE $(40,374) ----------- TOTAL $6,632,969 ===========